Healthcare-Associated Infection Testing (HAI) - The "Prevention Effect" on Diagnostic Markets
Healthcare-Associated Infection Testing (HAI) - The "Prevention Effect" on Diagnostic Markets takes a multi-dimensional look at the testing for healthcare-associated infections (HAIs), as it looks at both prevention procedures such as sterilization and surface area disinfection and testing products such as molecular tests and immunoassays. The testing market and prevention markets are treated as separate segments, but for hospital and healthcare facility customers these two markets interplay. Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases, and monies spent on these activities can reduce testing activities. How large is this effect, and how long will it last? What is the size of the market for healthcare infections testing and prevention? What are the top companies in the market? What is the expected growth in the future? This report answers these questions and more.
This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays. Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection.
An HAI may occur in a postoperative wound or as a complication unrelated to the disease or condition. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20, or 5%, of hospitalized patients will contract an HAI. Worldwide, the rate of nosocomial infections is between 3.5% and 12% of admissions in developed regions.
The Prevention Market Incorporates Technologies and Consumables Including:
Heat/steam sterilization systems
Chemical sterilization systems and consumables
Radiation sterilization technologies
Sterilization verification system
The Testing Market Incorporates Diagnostic Equipment and Consumes for Infection Detection and Treatment Including:
Microbial identification and sensitivity tests
Molecular and DNA tests
To prevent infection, all possible measures are taken to create and maintain a therapeutic environment for the patient and healthcare workers.
In recent years, there have been improved methods for testing infected patients. For example, testing for MRSA infections can be done via a nostril swab, now an effective option in detecting bacteria. Admission screening has been effective in some areas and has reduced the spread of MRSA infections in hospitals in the United States and some European countries.
In some European countries, including the United Kingdom, screening for aggressive infections such as MRSA is performed in many hospitals upon admission.
This Report Covers Areas Including:
Markets for HAI Testing and HAI Prevention, 2016-2021
Description of Infections
Hospital Spending Priorities
Cost of HAIs
The Basics - About Nosocomial Infections (HAIs)
Prevention Segments for Disinfectants, Sterilization and Wide Area Disinfection
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend").
Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.